Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers

Richard L. Lalonde, Robert J. Straka, John A. Pieper, Michael B. Bottorff, David M. Mirvis

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

In an attempt to evaluate the propranolol (P) concentration-effect relationship, percentage reduction in exercise heart rate was modeled as a function of unbound and total P concentrations using the linear, Emax, and sigmoid Emaxmodels. Nine volunteers underwent repeated treadmill exercise tests over 48 hr during a control period, after receiving 160 mg of P orally and again after receiving 160 mg once daily for 7 days. Beta blockade was assessed as the percentage reduction in exercise heart rate compared to control. Total serum P concentrations were determined by HPLC and unbound fractions by equilibrium dialysis. Using nonlinear least-squares regression, the Emaxmodel was best in describing the concentration-effect relationship in each subject. Mean parameters for combined single dose and steady state were Emax33.6±4.5% and EC5018.2±15.6ng/ml for total P and Emax33.5±4.3% and EC501.66±1.56 for unbound P. Model fits were not significantly better for unbound versus total P and EC50values showed similar intersubject variability. The observed unbound EC50values are consistent with reported receptor dissociation constants. Therefore the large intersubject variability in EC50could not be accounted for by variability in P protein binding.

Original languageEnglish (US)
Pages (from-to)569-582
Number of pages14
JournalJournal of Pharmacokinetics and Biopharmaceutics
Volume15
Issue number6
DOIs
StatePublished - Dec 1 1987

Keywords

  • exercise heart rate
  • pharmacodynamic modeling
  • propranolol
  • unbound and total concentration

Fingerprint Dive into the research topics of 'Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers'. Together they form a unique fingerprint.

Cite this